Hemochromatosis-associated mortality in the United States from 1979 to 1992: An analysis of multiple-cause mortality data

Annals of Internal Medicine

Volumn 129, Issue 11, 1998, Pages 946-953

  Yang, Quanhe ^a,c   McDonnell, Sharon M ^a,b   Khoury, Muin J ^a,b   Cono, Joanne ^a   Parrish, R Gibson ^a,c  

^a EMORY UNIVERSITY   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c NATIONAL CENTER FOR ENVIRONMENTAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CARDIOMYOPATHY; CHILD; DIABETES MELLITUS; FEMALE; HEMOCHROMATOSIS; HUMAN; INFANT; LIVER CANCER; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; POPULATION RESEARCH; PRIORITY JOURNAL; UNITED STATES;

EID: 0032401683     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-129-11_part_2-199812011-00005     Document Type: Article

References (42)

1. Witte DL, Crosby WH, Edwards CQ, Fairbanks VF, Mitros FA. Practice guideline development task force of the College of American Pathologists. Hereditary hemochromatosis. Clin Chim Acta. 1996;245:139-200.
2. Rouault TA. Hereditary hemochromatosis. JAMA. 1993;269:3152-4.
3. Edwards CQ, Cartwright GE, Skolnick MH, Amos BD. Homozygosity for hemochromatosis: clinical manifestations. Ann Intern Med. 1980;93:519-25.
4. Niederau C, Fischer R, Sonnenberg A, Stremmel W, Trampisch HJ, Strohmeyer G. Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis. N Engl J Med. 1985;313:1256-62.
5. Neiderau C, Fischer R, Purschel A, Stremmel W, Haussinger D, Strohmeyer G. Long-term survival in patients with hereditary hemochromatosis. Gastroenterology. 1996;110:1107-19.
6. Edwards CQ, Griffen LM, Goldgar D, Drummond C, Skolnick MM, Kushner JP. Prevalence of hemochromatosis among 11,065 presumably healthy blood donors. N Engl J Med. 1988;318:1355-62.
7. McLaren CE, Gordeuk VR, Looker AC, Hasselblad V, Edwards CQ, Griffen LM, et al. Prevalence of heterozygotes for hemochromatosis in the white population of the United States. Blood. 1995;86:2021-7.
8. Edwards CQ, Kushner JP. Screening for hemochromatosis. N Engl J Med. 1993;328:1616-20.
9. Iron overload disorders among Hispanics - San Diego, California, 1995. MMWR Morb Mortal Wkly Rep. 1996;45:991-3.
10. Barton JC, Edwards CQ, Bertoli LF, Shroyer TW, Hudson SL. Iron overload in African Americans. Am J Med. 1995;99:616-23.
11. Gable CB. Hemochromatosis and dietary iron supplementation: implications from US mortality, morbidity, and health survey data. J Am Diet Assoc. 1992; 92:208-12.
12. Israel RA, Rosenberg HM, Curtin LR. Analytical potential for multiple cause-of-death data. Am J Epidemiol. 1986;124:161-79.
13. Hennekens CH, Buring JF. Measures of disease frequency. In: Mayrent SL, ed. Epidemiology in Medicine. Boston: Little, Brown; 1987.
14. Ahlbom A. Biostatistics for Epidemiologists. Boca Raton, FL: Lewis Publishers; 1993.
15. Crosby WH. Hemochromatosis: current concepts and management. Hosp Pract (Off Ed). 1987;22:173-7.
16. Powell LW, Summers KM, Board PG, Axelsen E, Webb S, Halliday JW. Expression of hemochromatosis in homozygous subjects. Implications for early diagnosis and prevention. Gastroenterology. 1990;98:1625-32.
17. Cartwright GE. Hemochromatosis. In: Wintrobe MM, ed. Harrison's Principles of Internal Medicine. 7th ed. New York: McGraw-Hill; 1974:618-9.
18. Finch SC, Finch CA. Idiopathic hemochromatosis, iron storage disease: iron metabolism in hemochromatosis. Medicine. 1955;34:381-430.
19. MacSween RN, Scott AR. Hepatic cirrhosis: a clinico-pathological review of 520 cases. J Clin Pathol. 1973;26:936-42.
20. MacDonald RA. Hemochromatosis and cirrhosis in different geographic areas. Am J Med Sci. 1965;249:36-46.
21. Knisely AS. Neonatal hemochromatosis. Adv Pediatr. 1992;39:383-403.
22. Bothwell TH. Overview and mechanisms of iron regulation. Nutr Rev. 1995; 53:237-45.
23. Moirand R, Adams PC, Bicheler V, Brissot P, Deugnier Y. Clinical features of genetic hemochromatosis in women compared with men. Ann Intern Med. 1997;127:105-10.
24. Baur MP, Danilovs JA. Histocompatibility testing: population analysis of HLA-A, B, C, DR, and other genetic markers. UCLA Tissue Registry. 1980 Joint Report 955-993.
25. Conrad ME. Sickle cell disease and hemochromatosis. Am J Hematol. 1991; 38:150-2.
26. Gordeuk V, Mukiibi J, Hasstedt SJ, Samowitz W, Edwards CQ, West G, et al. Iron overload in Africa. Interaction between a gene and dietary iron content. N Engl J Med. 1992;326:95-100.
27. Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet. 1996;13:399-408.
28. Carella M, D'Ambrosio L, Totaro A, Grifa A, Valentino MA, Piperno A, et al. Mutation analysis of the HLA-H gene in Italian hemochromatosis patients. Am J Hum Genet. 1997;60:828-32.
29. Bradley LA, Haddow JE, Palomaki GE. Population screening for haemochromatosis: a unifying analysis of published intervention trials. J Med Screen. 1996;3:178-84.
30. Adams PC, Valberg LS. Evolving expression of hereditary hemochromatosis. Semin Liver Dis. 1996;16:47-54.
31. Hurwitz ES, Holman RC, Strine TW, Chorba TL. Chronic liver disease mortality in the United States, 1979 through 1989. Am J Public Health. 1995;85:1256-60.
32. Sullivan JL. The iron paradigm of ischemic heart disease. Am Heart J. 1989; 117:1177-88.
33. McCord JM. Is iron sufficiency a risk factor in ischemic heart disease? Circulation. 1991;83:1112-4.
34. Sullivan JL. Stored iron and ischemic heart disease. Empirical support for a new paradigm [Editorial]. Circulation. 1992;86:1036-7.
35. Sempos CT, Looker AC, Gillum RF, Makuc DM. Body iron stores and the risk of coronary heart disease. N Engl J Med. 1994;330:1119-24.
36. Sempos CT, Looker AC, Gillum RF. Iron and heart disease: the epidemiologic data. Nutr Rev. 1996;54:73-84.
37. Lynch SR, Baynes RD. Deliberations and evaluations of the approaches, endpoints and paradigms for iron dietary recommendations. J Nutr. 1996; 126(9 Suppl):2404S-9S.
38. Knekt P, Reunanen A, Takkunen H, Aromaa A, Heliovaara M, Hakulinen T. Body iron stores and risk of cancer. Int J Cancer. 1994;56:379-82.
39. Stevens RG, Graubard BI, Micozzi MS, Neriishi K, Blumberg BS. Moderate elevation of body iron level and increased risk of cancer occurrence and death. Int J Cancer. 1994;56:364-9.
40. Kuller LH. The use of existing databases in morbidity and mortality studies [Editorial]. Am J Public Health. 1995;85:1198-200.
41. Yang Q, Khoury MJ, Mannino D. Trends and patterns of mortality associated with birth defects and genetic diseases in the United States, 1979-1992: an analysis of multiple-cause mortality data. Genet Epidemiol. 1997; 14:493-505.
42. Gittelsohn A, Royston PN. Cause of death validation: review of literature and annotated bibliography. Washington, DC: National Center for Health Statistics; final progress report NCHS HRA 230-0032; 1978.